Form 4: BioLife Solutions Director Amy DuRoss Reports Stock Transactions
SEC Form 4 Filing
Director Amy DuRoss reports acquisition and disposal of BioLife Solutions (BLFS) common stock.
Summary
- On March 8, 2024, Amy DuRoss acquired 11,264 shares of BioLife Solutions common stock.
- On March 12, 2024, DuRoss sold 6,135 shares at an average price of $16.86.
- On March 13, 2024, DuRoss sold 5,065 shares at an average price of $17.
- Following these transactions, DuRoss directly owns 29,443 shares of BioLife Solutions common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, reflecting routine stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the director's trading activity.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Stakeholder Impact
- The transactions may be of interest to shareholders as they provide insight into the actions of a company director.
Key Dates
| Date | Description |
|---|---|
| 03/08/2024 | Acquisition of 11,264 shares of common stock |
| 03/12/2024 | Sale of 6,135 shares of common stock at an average price of $16.86 |
| 03/13/2024 | Sale of 5,065 shares of common stock at an average price of $17 |
| 03/13/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.